Recently, President Trump issued a series of Executive Orders that aim to lower prescription drug costs, including an Executive Order that is similar to the Administration’s 2018 proposed “International Pricing Index Model for Medicare Part B Drugs.” While the White House has yet to release specific details about this new effort, the Administration has signaled
August
7
2020